Anavex Life Sciences Corp. (AVXL)
4.105
+0.02
(+0.61%)
USD |
NASDAQ |
Dec 11, 16:00
4.105
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Research and Development Expense (Quarterly): 7.295M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 22.56M |
| ADMA Biologics, Inc. | 1.528M |
| Aldeyra Therapeutics, Inc. | 5.431M |
| ACADIA Pharmaceuticals, Inc. | 87.83M |
| CorMedix, Inc. | 5.098M |